GOSS
Price:
$0.1619
Market Cap:
$38.00M
Gossamer Bio, Inc. operates as a U.S.-based, clinical-stage biopharmaceutical company. Its primary objective is to discover, acquire, advance, and market novel therapeutic solutions, specifically addressing conditions within immunology, inflammatory diseases, and oncology. The company's pipeline highlights several key drug candidates: GB002: An inhaled small molecule designed to inhibit platelet-derived growth factor receptor (PDGFR), colony-stimulating factor 1 receptor (CSF1R), and c-KIT, currently being developed for pulmonary arterial hypertension. GB004: An oral, gut-targeted small molecule in development for treating inflammatory bowel disease. GB5121: An oral, irreversible covalent sm...[Read more]
Industry
Biotechnology
IPO Date
2019-02-08
Stock Exchange
NASDAQ
Ticker
GOSS
According to Gossamer Bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 199.90M. This represents a change of -66.05% compared to the average of 588.78M of the last 4 quarters.
The mean historical Enterprise Value of Gossamer Bio, Inc. over the last ten years is 548.01M. The current 199.90M Enterprise Value has changed 3.55% with respect to the historical average. Over the past ten years (40 quarters), GOSS's Enterprise Value was at its highest in in the June 2019 quarter at 1.25B. The Enterprise Value was at its lowest in in the March 2017 quarter at 0.
Average
548.01M
Median
418.69M
Minimum
164.33M
Maximum
978.39M
Discovering the peaks and valleys of Gossamer Bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 174.57%
Maximum Annual Enterprise Value = 978.39M
Minimum Annual Increase = -64.95%
Minimum Annual Enterprise Value = 164.33M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 872.65M | 141.43% |
| 2024 | 361.45M | -6.41% |
| 2023 | 386.19M | 29.90% |
| 2022 | 297.29M | -64.95% |
| 2021 | 848.31M | 135.53% |
| 2020 | 360.17M | -52.62% |
| 2019 | 760.11M | -22.31% |
| 2018 | 978.39M | 116.84% |
| 2017 | 451.20M | 174.57% |
The current Enterprise Value of Gossamer Bio, Inc. (GOSS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
540.10M
5-year avg
553.18M
10-year avg
548.01M
Gossamer Bio, Inc.’s Enterprise Value is less than KalVista Pharmaceuticals, Inc. (1.49B), less than 4D Molecular Therapeutics, Inc. (409.65M), less than Olema Pharmaceuticals, Inc. (810.53M), less than Ventyx Biosciences, Inc. (982.56M), less than Lexicon Pharmaceuticals, Inc. (872.47M), less than Rigel Pharmaceuticals, Inc. (629.10M), greater than Prothena Corporation plc (110.11M), less than Corvus Pharmaceuticals, Inc. (963.93M), less than RAPT Therapeutics, Inc. (923.92M), less than REGENXBIO Inc. (400.14M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.49B | $1.44B | |
| 409.65M | $461.60M | |
| 810.53M | $862.12M | |
| 982.56M | $1.00B | |
| 872.47M | $852.86M | |
| 629.10M | $607.79M | |
| 110.11M | $431.91M | |
| 963.93M | $1.00B | |
| 923.92M | $959.26M | |
| 400.14M | $344.31M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gossamer Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Gossamer Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Gossamer Bio, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Gossamer Bio, Inc. (GOSS)?
What is the 3-year average Enterprise Value for Gossamer Bio, Inc. (GOSS)?
What is the 5-year average Enterprise Value for Gossamer Bio, Inc. (GOSS)?
How does the current Enterprise Value for Gossamer Bio, Inc. (GOSS) compare to its historical average?